Company intelligence / Profile preview
Estuary Biotherapeutics, Inc.
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
Overview
Estuary Biotherapeutics is an early-stage biotechnology company founded in August 2022 and based in Menlo Park, California. The company is led by Wayne Sackett (Co-Founder & CEO), who has a strong track record in business development within the biotech sector. While specific details about its pipeline, therapeutic focus, and technology platform are not public as of May 2025, the company's leadership and advisory connections suggest a focus on innovative therapies for serious diseases—potentially rare genetic conditions—leveraging experience from prior roles at MyoKardia and other life science ventures.[1][2][3][4]
- Therapeutic areas
- Rare Diseases
- Modalities
- Not explicitly stated; likely genetic medicines or biologic therapeutics based on founder’s background and company positioning[3][5]
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Estuary Biotherapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Estuary Biotherapeutics, Inc..